Bristol-Myers Squibb

Bristol-Myers Squibb

Yahoo Finance • yesterday

CNS Summit Announces Sanofi as No. 1 in the 2026 Digital Innovation Index

BOSTON, Nov. 4, 2026 /PRNewswire/ -- Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index, developed in collaboration with IDEA Pharma, a division of SAI MedPartners, placing in the top three in all three categories. The ran... Full story

Yahoo Finance • 3 days ago

BMY Q3 deep dive: pipeline advances offset margin pressure as guidance shifts

BMY Q3 deep dive: pipeline advances offset margin pressure as guidance shifts Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q3 2026 results beating Wall Street's revenue expectations , with sales up 6.9% year on year... Full story

Yahoo Finance • 3 days ago

What Invesco S&P Ultra Dividend Revenue ETF (RDIV) Bought: Chevron Leads on Oct. 29

This article first appeared on GuruFocus. Invesco S&P Ultra Dividend Revenue ETF (RDIV) was the sole ETF buying on Thursday, Oct. 29, with no funds selling. RDIV added $239.2 million of stock and sold nothing, increasing all 60 of its pos... Full story

Yahoo Finance • 3 days ago

What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Oct. 29

This article first appeared on GuruFocus. State Street Health Care Select Sector SPDR ETF (XLV) reported $423.4 million in ETF activity last Thursday, all of it buying. The $49.10 billion fund increased all 60 of its positions and decreas... Full story

Yahoo Finance • 3 days ago

ETFs Are Net Sellers of Apple (AAPL) on Oct. 29

This article first appeared on GuruFocus. Apple (AAPL) drew net ETF selling in Thursday's session, snapping a two-day run of inflows. ETFs sold $491.5 million of the stock on the day, with 53 funds buying and 26 selling more funds traded... Full story

Yahoo Finance • 3 days ago

ETFs Bought $22.0 Million of Merck (MRK) on Oct. 29

This article first appeared on GuruFocus. ETFs bought $22.0 million of Merck (MRK) on Thursday, with 36 funds adding shares against 20 that sold. ETF activity has favored the stock for four straight sessions, including $19.1 million on We... Full story

Yahoo Finance • 5 days ago

What Bristol Myers Squibb Stock's Earnings Beat Means For Shareholders

Bristol-Myers Squibb reported Q3 2026 revenue of US$13.07b and net income of US$2.16b, beating analyst expectations and prompting higher full-year sales guidance, while EPS guidance was updated after an 11.57% earnings surprise. The firm p... Full story

Yahoo Finance • 7 days ago

AI CRM Adoption Could Be A Key Catalyst For Veeva Systems Stock (VEEV)

Veeva Systems recently hosted its Commercial Summit Europe in Copenhagen, where leaders from AstraZeneca, Bristol Myers Squibb, Roche and others shared how industry specific AI and Veeva's Commercial Cloud and Data Cloud tools support cust... Full story

Yahoo Finance • 7 days ago

The Big Caveat Behind Bristol Myers' Sales Guidance Boost

Bristol Myers Squibb stock rose Thursday despite a "mixed bag" performance that included a miss from its biggest cancer drug. Continue Reading... Full story

Yahoo Finance • 7 days ago

Bristol Myers Slips: Opdivo Sales Come Up Short, Earnings Guidance Cut

Bristol Myers Squibb stock dipped early Thursday on lighter-than-expected Opdivo sales and an earnings guidance haircut. Continue Reading... Full story

Yahoo Finance • 7 days ago

Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026

Annovis Bio Inc. Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company")... Full story

Yahoo Finance • 7 days ago

Stock market today: Dow rises, S&P 500 and Nasdaq futures fall as Alphabet stock sells off, AI jitters return

US stock futures diverged in premarket trading on Thursday as Alphabet's Q3 earnings sparked a sell-off in the stock and AI jitters returned to markets, dragging on the tech-heavy indexes. Futures on the Dow Jones Industrial Average (YM=F... Full story

Yahoo Finance • 9 days ago

Bristol Myers Squibb (BMY) Stock Fair Value Edges Lower On Split Analyst Views

The consolidated fair value estimate for Bristol-Myers Squibb has shifted from US$66.71 to US$65.25, which frames the latest round of price target debates. Recent research highlights how views on ALOFT-IPF data, the broader pipeline and po... Full story

Yahoo Finance • 10 days ago

The Conference Board Announces 2027 Corporate Citizenship Award Honorees: Bristol Myers Squibb, Cargill, Navy Federal Credit Union, Science Applications International Corporation (SAIC), TD, and The Mosaic Company

NEW YORK, Oct. 26, 2026 /PRNewswire/ -- The Conference Board is pleased to announce the honorees of its fourth annual Corporate Citizenship Awards. The recipients will be honored at a special awards dinner on April 13, 2027, in New York Ci... Full story

Yahoo Finance • 10 days ago

Google, Microsoft, Amazon, and the Fed step up to a skittish market: What to watch this week

The first week of Big Tech earnings looked promising — until Thursday hit. After SpaceX (SPCX), Meta (META), and Tesla (TSLA) opened their books without signaling ballooning spending next year, the reality that longer-term projects would,... Full story

Yahoo Finance • 11 days ago

Roche lung cancer drug extends survival by nearly six months in late-stage trial

[Roche Diagnostics campus facade in Silicon Valley] Michael Vi/iStock Editorial via Getty Images Roche Holding (RHHBF [https://seekingalpha.com/symbol/RHHBF]) (RHHBY [https://seekingalpha.com/symbol/RHHBY]) (RHHVF [https://seekingalpha.co... Full story

Yahoo Finance • 11 days ago

Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more

[Rolled newspaper with the headline Quarterly Results] Zerbor Another heavyweight earnings week is ahead, with results from Big Tech, energy giants, chipmakers, financial services, healthcare, and industrial leaders set to offer a broad r... Full story

Yahoo Finance • 11 days ago

BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy

BioNTech SE Pumitamig plus docetaxel demonstrated encouraging responses in squamous and non-squamous non-small cell lung cancer across PD-L1 expression levels with a confirmed objective response rate of 36.7% following progression on or a... Full story

Yahoo Finance • 13 days ago

Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks

Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today... Full story

Yahoo Finance • 13 days ago

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index dropping 1.3% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story